top of page

The Ultimate Guide to Streamlining Patient Administration Processes

May 7, 2024
1 min read

For most patients administration of a theranostic is relatively very well tolerated.

During administration of the therapy a a lead shielded syringe containing the liquid radioactive theranostic is brought into the patient room.

The theranostic is slowly injected into the patients arm and into the bloodstream. Administration is typically a couple of hours and patients may have further treatments usually at 4-6 week intervals.

 
 
Oncothera ICON white

Oncothera Advocacy is the Voice for Theranostics

Support Us

Quick Links

Small Print

Privacy Policy

Disclaimer

Site developed by
 Showoff Group.

ACNC registration logo

Oncothera Advocacy is a Registered Charity with the Australian Charities and Not–for–profit Commission.

Acknowledgement of Country

Oncothera Advocacy acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Custodians of the lands on which we live, work and connect. We pay our respects to Elders past and present, and recognise their continuing connection to land, waters, culture and community.

Commitment to Inclusion

Oncothera Advocacy is committed to an inclusive healthcare community where everyone is treated with dignity, respect and equity. We welcome and support people of all backgrounds, cultures, identities, genders and sexual orientations, including LGBTQIA+ communities.

bottom of page